Tax Management India. Com
Law and Practice  :  Digital eBook
Research is most exciting & rewarding
  TMI - Tax Management India. Com
Follow us:
  Facebook   Twitter   Linkedin   Telegram

Home Case Index All Cases VAT and Sales Tax VAT and Sales Tax + HC VAT and Sales Tax - 2020 (6) TMI HC This

  • Login
  • Cases Cited
  • Summary

Forgot password       New User/ Regiser

⇒ Register to get Live Demo



 

2020 (6) TMI 549 - HC - VAT and Sales Tax


Issues:
1. Interpretation of Entry 25 of Schedule C of HVAT Act
2. Classification of Black Disinfectant Fluid (BDF) under Entry 25 of Schedule C
3. Application of common parlance test in interpreting fiscal statutes
4. Reliance on definition of 'drug' under the Drugs and Cosmetics Act, 1940
5. Consideration of BDF as a drug under Schedule C of the 2003 Act
6. Use of residuary entry in tax classification

Interpretation of Entry 25 of Schedule C:
The appeal raised questions regarding the interpretation of Entry 25 of Schedule C of the HVAT Act. The Tribunal had to determine if Black Disinfectant Fluid (BDF) falls under this specific entry.

Classification of Black Disinfectant Fluid:
The Tribunal concluded that BDF is indeed covered under Entry 25 of Schedule C of the 2003 Act. The appellant argued that BDF does not fit the definition of 'drug' as intended by the legislature. However, the Tribunal relied on the common parlance test to interpret the entry, emphasizing how goods are understood by those dealing with them.

Application of Common Parlance Test:
The judgment extensively discussed the application of the common parlance test in interpreting fiscal statutes. Citing various legal precedents, the court emphasized understanding terms in their popular sense, as perceived by individuals involved in the relevant industry.

Reliance on Definition of 'Drug':
In the absence of a specific definition under the 2003 Act, the Tribunal appropriately relied on the definition of 'drug' provided in Section 3(b) of the Drugs and Cosmetics Act, 1940. This definition includes substances used for diagnosis, treatment, or prevention of diseases in humans or animals.

Consideration of BDF as a Drug:
The Tribunal's decision to classify BDF as a drug under Entry 25 of Schedule C was supported by evidence from the Assistant State Drug Controller, confirming BDF's categorization as a drug under the 1940 Act. The court noted that BDF's usage as a disinfectant aligned with the definition of 'drug' under the legislation.

Use of Residuary Entry:
The appellant's argument to classify BDF under the residuary entry was dismissed as BDF was found to be specifically covered under Entry 25 of Schedule C. Legal precedent highlighted that if a product fits a specific entry, resorting to the residuary entry is not warranted.

In conclusion, the appeal was dismissed, affirming the Tribunal's decision that BDF falls under Entry 25 of Schedule C of the 2003 Act. The judgment underscored the importance of applying the common parlance test and relying on relevant definitions to interpret tax classifications accurately.

 

 

 

 

Quick Updates:Latest Updates